Christen Harm is Pharmaceutical Executive's Associate Editor. Email her at charm@mmhgroup.com
Pharmaceutical Executive
On episode 6, Michelle and Christen talk to Lara Sullivan, founder and president of SpringWorks Therapeutics, about the differences in working for legacy pharma vs. small biotech start-ups.
On episode 6, Michelle and Christen talk to Lara Sullivan, founder and president of SpringWorks Therapeutics, about the differences in working for legacy pharma vs. small biotech start-ups.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
